Systemic immunosuppressive therapy in juvenile idiopathic arthritis-associated uveitis
Open Access
- 2 April 2026
- journal article
- research article
- Published by Springer Nature in International Ophthalmology
- Vol. 46 (1) , 183
Abstract
No abstract availableKeywords
Funding Information
- Ege Üniversitesi
This publication has 33 references indexed in Scilit:
- Efficacy and Safety of Anti-TNFα Therapy for Uveitis Associated with Juvenile Idiopathic Arthritis: A Systematic Review and Meta-AnalysisRheumatology and Therapy, 2021
- Juvenile idiopathic arthritis-associated uveitisBest Practice & Research Clinical Rheumatology, 2017
- CHRONIC ARTHRITIS IN CHILDHOOD2011
- Retrospective analysis of children with uveitis treated with infliximabJournal of American Association for Pediatric Ophthalmology and Strabismus, 2008
- Biological and clinical effects of anti-TNFα treatmentAutoimmunity Reviews, 2007
- Do tumor necrosis factor inhibitors cause uveitis? A registry‐based studyArthritis & Rheumatism, 2007
- Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: A long‐term followup studyArthritis & Rheumatism, 2007
- Juvenile idiopathic arthritisAutoimmunity Reviews, 2006
- Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic diseaseArthritis & Rheumatism, 2001
- Juvenile arthritis and uveitisSurvey of Ophthalmology, 1990